Ducommun: Missile Program Growth Can Outrun Boeing Destocking - A Mid-Term Long Trade

Hook & thesis

Ducommun (DCO) has the profile of a classic defense-supplier rebound: core businesses tied to rising missile and defense electronics demand even as one large commercial customer - Boeing - trims inventories. I see the current setup as a concrete trade opportunity: the market has partially priced in Boeing-related headwinds, but accelerating defense programs and solid revenue multiple support a mid-term long position.

Our trade idea is simple and actionable: buy at $126.84, place a stop at $116.00 and target $140.00 over a mid-term horizon (45 trading days). This plan balances upside from stronger missile/electronics bookings against the real risk of continued commercial aerospace destocking and near-term cash-flow pressure.

What Ducommun does and why the market should care

Ducommun is an engineering and manufacturing supplier to aerospace, defense, industrial and medical markets. It operates through Electronic Systems - providing electronic and electromechanical products - and Structural Systems - manufacturing contoured aero structure components and bonded composite/metal structures. That dual exposure matters: structural work is sensitive to commercial OEM cycles, while electronic and defense systems get direct lift from military spending and urgent missile programs.

The market cares because Ducommun sits at the intersection of two divergent drivers right now: commercial aerospace faces a destocking phase, notably from Boeing, which pressures aerospace supply chains; conversely, defense spending - particularly for missiles, air defense, and avionics - is accelerating. For a company with both structural and electronic capabilities, that shift can reweight revenue toward higher-growth, less cyclical defense programs.

Supporting numbers

• Market cap: $1.90B (snapshot market cap $1,900,944,364.76).
• Enterprise value: $2.153B.
• EV/Sales: 2.61; Price/Book: 2.86.
• Trailing EPS: -$2.26 (negative), and free cash flow was negative at -$48.64M.
• Profitability metrics show strain: ROA -2.86% and ROE -5.13%, reflecting recent margin and cash-flow pressure.

Those numbers tell a nuanced story. Valuation is not stretched relative to the company's small-cap growth profile - EV/Sales of ~2.6 is reasonable for a supplier with defense content. But profitability and FCF are weak, so upside hinges on revenue mix improvement and margin stabilization as defense work replaces commercial structural volume.

Technical and market context

Price action shows constructive short-term momentum: the 10-day SMA is $122.85 and the stock sits above its 20- and 50-day SMAs, with the 50-day at $120.95 suggesting a higher-low base. RSI at ~54 is neutral-to-healthy. Short interest has come down into the 300k range with days-to-cover near 1.75 recently, but short-volume readings in late March show active shorting on volatile days - a potential source of squeezes if positive catalysts arrive.

Valuation framing

At a market cap near $1.9B and EV of $2.15B, Ducommun trades at an EV/Sales multiple that is consistent with a supplier transitioning toward higher defense content. Price/Book near 2.86 looks elevated for a company with negative EPS, but reasonable if one assigns a premium to predictable defense revenue. The negative EPS and weak free cash flow are real negatives; they cap near-term upside unless bookings and cash generation improve.

Absent direct peer multiples in the dataset, think of valuation qualitatively: the market is paying for program backlog, engineering content, and the ability to capture long-duration defense contracts. If missile and defense electronics bookings accelerate and margins firm, a move toward or above the 52-week high of $140.02 is plausible; absent that, the stock is vulnerable to re-rating back toward more conservative supplier multiples.

Catalysts to drive the trade

• Defense procurement tailwinds: broader defense spending increases and focused missile/air defense programs should raise bookings for electronic and electromechanical products.
• Company earnings and call cadence: the management-hosted calls (historically used to set guidance) provide clarity; the next print following the February 26, 2026 Q4 release period will be a catalyst for sentiment.
• Program awards / contract wins: any announced missile or avionics program wins would materially change revenue mix and investor perception.
• Stabilizing FCF / margin improvement: signs of positive free cash flow or narrowing losses would validate valuation and attract multiple expansion.

Trade plan (actionable)

Direction: Long DCO

Entry price: $126.84

Stop loss: $116.00

Target: $140.00

Horizon: mid term (45 trading days). This horizon gives time for Q-over-Q bookings to show up in public disclosures and for defense program news to influence the order book and guidance. It also captures the potential technical retest and retake of the 52-week high near $140.

Rationale: entry is at current market levels with stop placement below the recent support band and 50-day SMA to limit downside if Boeing-related destocking deepens or guidance deteriorates. The $140 target is near the 52-week high ($140.02) and represents a realistic near-term upside if defense demand drives revenue reweighting and sentiment improves.

Risks and counterarguments

Below are the principal risks that could invalidate this trade or reduce its expected return:

• Commercial aerospace destocking persists or intensifies. Boeing remains a major industry driver; a prolonged multi-quarter destocking cycle would keep structural systems revenue depressed and pressure margins.
• Negative free cash flow and weak EPS. Trailing free cash flow is -$48.64M and EPS is -$2.26. If cash burn continues or capital needs rise, the stock could re-rate lower.
• Contract timing and backlog transparency. Defense awards can be lumpy; if anticipated program wins are delayed or smaller than expected, revenue and guidance misses would hurt the stock.
• Macro and defense budget risk. While recent headlines show defense spending momentum, funding timelines and political decisions can shift, affecting program pace.
• Short activity and technical downside. Elevated short-volume spikes indicate hedged positioning that can accelerate downside during negative news.

Counterargument to the thesis

One credible counterargument is that the market has already priced in defense upside and that Ducommun's structural exposure to Boeing is sufficiently large that any sustained OEM weakness will outweigh modest defense wins. Given negative profitability and cash flow, the company could need to accept lower margins on defense work or take on near-term cost that compresses earnings further. In that case, a rally to $140 would be unlikely without a marked improvement in FCF or a sizable contract award that materially shifts revenue composition.

What would change my mind

I would reconsider this long trade if management signals persistent margin erosion on the Structural Systems side tied to Boeing destocking that is expected to last multiple quarters, or if quarterly FCF remains deeply negative without a credible plan to return to positive cash generation. Conversely, I would become more bullish if the company reports material program awards for missile or defense electronics, posts a positive swing in free cash flow, or updates guidance upward on defense backlog that implies durable mid-single to high-single digit revenue growth.

Conclusion

Ducommun is a trade where program mix matters more than headline revenue. The business combines cyclical structural work with more defensive and growing electronic/defense programs. Given a market cap of ~$1.9B, EV/Sales of ~2.6, and a stock sitting above key moving averages, the risk/reward favors a mid-term long if you believe defense demand and missile program awards will offset Boeing-related destocking.

Execute a disciplined long: entry $126.84, stop $116.00, and target $140.00 over 45 trading days. That plan balances upside tied to defense catalysts against the material risks embedded in negative cash flow and OEM exposure. Monitor near-term contract announcements, quarterly guidance, and free cash flow trends closely - those datapoints will determine whether Ducommun is on a sustainable path higher or headed back into a cyclically depressed valuation band.

Key facts snapshot